Wetherby Asset Management Inc Abiomed Inc Transaction History

Wetherby Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $167,873 - $252,964	-747 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $21,071 - $27,838	-76 Reduced 9.23%	747 $247,000
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $5,411 - $6,684	18 Added 2.24%	823 $296,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $2,791 - $3,385	9 Added 1.13%	805 $262,000
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $5,779 - $7,725	-22 Reduced 2.69%	796 $248,000
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $3,431 - $4,261	12 Added 1.49%	818 $261,000
Q4 2020 Feb 11, 2021	SELL	$251.88 - $324.2 $9,319 - $11,995	-37 Reduced 4.39%	806 $261,000
Q3 2020 Dec 16, 2020	SELL	$255.22 - $317.0 $255 - $317	-1 Reduced 0.12%	843 $234,000
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $119,341 - $216,983	844 New	844 $204,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.